1169P Aggregated cancer registry data from Norway to create an external cohort for patients with metastatic NSCLC squamous cell carcinoma

Abstract

It is not uncommon that oncology clinical trials are conducted with few patients and/or as single arm studies. This leaves both researchers and regulatory bodies with less opportunity to perform any comparative evaluation of effect between new treatment intervention and a given standard of care (SoC) treatment. We investigated if aggregated data from the CRN could be used to create a RW- registry cohort of patients with metastatic squamous cell NSCLC, treated with chemotherapy in 1L. We also analyzed survival in the group and did a non-validated comparison of survival from a similar patient group from published phase III trials.